Beranda › Glioma
Uji klinis Glioma yang merekrut di AS
118 studi untuk Glioma merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY25 studi
- Houston, TX23 studi
- Boston, MA20 studi
- Washington, DC19 studi
- Philadelphia, PA16 studi
- Miami, FL15 studi
- Columbus, OH15 studi
- San Francisco, CA14 studi
- Chicago, IL13 studi
- Durham, NC12 studi
- Seattle, WA11 studi
- Aurora, CO10 studi
- St. Louis, MO10 studi
- Los Angeles, CA10 studi
- Cincinnati, OH9 studi
- Rochester, MN9 studi
- Queens, NY7 studi
- Edison, NJ7 studi
- Atlanta, GA7 studi
- Birmingham, AL6 studi
- Dallas, TX6 studi
- Jacksonville, FL6 studi
- Nashville, TN6 studi
- Orange, CA6 studi
- Baltimore, MD6 studi
- San Diego, CA6 studi
- Omaha, NE6 studi
- Ann Arbor, MI5 studi
- New Rochelle, NY5 studi
- San Antonio, TX5 studi
- Cleveland, OH5 studi
- Phoenix, AZ4 studi
- Staten Island, NY4 studi
- Greenburgh, NY4 studi
- East Norwalk, CT4 studi
- Mountain View, CA4 studi
- Salt Lake City, UT4 studi
- Arlington, VA4 studi
- New Haven, CT4 studi
- Tampa, FL4 studi
Berdasarkan negara bagian
- Alabama6 studi
- Arizona8 studi
- Arkansas3 studi
- California25 studi
- Colorado11 studi
- Connecticut6 studi
- Distrik Columbia14 studi
- Florida23 studi
- Georgia7 studi
- Illinois13 studi
- Indiana4 studi
- Iowa3 studi
- Maryland11 studi
- Massachusetts20 studi
- Michigan8 studi
- Minnesota13 studi
- Missouri11 studi
- Nebraska6 studi
- New Jersey10 studi
- New York28 studi
- North Carolina16 studi
- Ohio18 studi
- Pennsylvania19 studi
- Tennessee8 studi
- Texas26 studi
- Utah4 studi
- Virginia5 studi
- Washington11 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
MCT for the Harvard/UCSF ROBIN Center
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06000787Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07025226A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Menerima pesertaFase 1/2
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05099003Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05030298Language Network Prehab Via fMRI Neurofeedback
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07488780Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07326566Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Menerima pesertaFase 1/2
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07416188MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT03896568A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Menerima pesertaFase 1/2
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04094610Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
Menerima pesertaFase awal 1
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05555550ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Menerima pesertaFase 2
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06838676Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT04977375A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Menerima pesertaFase 1
Usia 5 hingga 18 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06357377Development of MRF for Characterization of Brain Tumors After Radiotherapy
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06101069MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT04373720A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Menerima pesertaFase 1
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05698524Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT04771806Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Menerima pesertaFase 1
36 Months · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07076498NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
Menerima pesertaFase 1
Usia 3 hingga 25 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07664176Targeted Pediatric High-Grade Glioma Therapy
Menerima pesertaStudi observasional
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Menerima pesertaFase 1
36 Months – 22 Years · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT03911388A Study of Mirdametinib in People With Central Nervous System Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07539441Assessing Brain Metabolism Using MRS With Deuterated Glucose
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06594315Study of Olutasidenib and Temozolomide in HGG
Menerima pesertaFase 2
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06161974Glioma Developmental and HyperActive Ras Tumor (DHART) Board
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT05489783Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.